Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 06:20:55 2026-10-01 am EDT			5-day change	1st Jan Change
2,774.50 ^INR	+0.25%		-1.50%	+12.28%

Aug. 03	GSK India first-quarter profit rises on steady vaccine demand	RE
Aug. 03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	470,017	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	21.51%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	470,017	470,017
Change	-	-18.99%	58.51%	48.08%	-20.64%	21.51%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	40.3x	35x
PBR	10.6x	12.9x	18.5x	25x	17.1x	17.7x	14.9x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.2x	2.3x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11x	9.95x
EV / Revenue	0x	0x	0x	0x	0x	11x	9.95x
EV / EBITDA	0x	0x	0x	0x	0x	31.7x	27.5x
EV / EBIT	0x	0x	0x	0x	0x	32x	27.5x
EV / FCF	0x	0x	0x	0x	0x	39.2x	35.7x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.55%	2.8%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.06%	1.06%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,774.50	2,774.50
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	40.34x	-	-	1.06%	4.89B
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	27.99x	6.52x	17.27x	2.17%	370.21B
Weighted average by Cap.	31.81x	7.61x	18.61x	1.96%